Corebridge Financial’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,020
Closed -$1.5M 2112
2025
Q1
$1.5M Sell
31,020
-135
-0.4% -$6.53K 0.01% 1095
2024
Q4
$1.2M Sell
31,155
-2,407
-7% -$92.9K 0.01% 1244
2024
Q3
$1.51M Buy
33,562
+2,122
+7% +$95.5K 0.01% 1169
2024
Q2
$1.09M Buy
+31,440
New +$1.09M 0.01% 1287